Company: Cipla Ltd. Category: Result Analysis


Cipla’s revenue of Rs40,119mn in 2QFY19 were down 2% YoY and up 2% QoQ and below our/consensus estimates by 2.2%/6.5%, respectively.
Nov. 6, 2018, 11:24 a.m.
Publisher: nirmalbang.com

Brokerages such as HSBC, Credit Suisse and Citi have downgraded the stock based on the company’s guidance ahead.
Nov. 6, 2018, 9:31 a.m.
Publisher: moneycontrol.com

NULL
Nov. 5, 2018, 2:36 p.m.
Publisher: moneycontrol.com

NULL
Nov. 5, 2018, 1:11 p.m.
Publisher: moneycontrol.com


The earnings before interest, taxes, depreciation and amortization (EBITDA) fell 13 percent year on year at Rs 702 crore from Rs 804 crore during the same quarter of last year.
Nov. 5, 2018, 12:53 p.m.
Publisher: moneycontrol.com

Net Sales are expected to increase by 8.8 percent Y-o-Y (up 12.7 percent Q-o-Q) to Rs. 4,440 crore, according to HDFC Securities.
Oct. 17, 2018, 5:37 p.m.
Publisher: moneycontrol.com

Net Sales are expected to increase by 7.8 percent Y-o-Y (up 11.7 percent Q-o-Q) to Rs. 4,401.4 crore, according to Sharekhan.
Oct. 16, 2018, 7:03 p.m.
Publisher: moneycontrol.com

Net Sales are expected to decrease by 1 percent Y-o-Y (up 2.6 percent Q-o-Q) to Rs. 4,042.4 crore, according to ICICI Direct.
Oct. 12, 2018, 4:39 p.m.
Publisher: moneycontrol.com

Cipla revenue grew by 11.7% YoY to Rs39.4bn (vs. estimates of Rs41bn) led by growth in domestic (22% YoY), South Africa (+23.2% YoY) and API biz (54% YoY).
Aug. 10, 2018, 10:26 a.m.
Publisher: trade.rsec.co.in

Drug major Cipla yesterday posted a 10 per cent increase in its consolidated net profit to Rs 451 crore for the first quarter ended June 30, driven by robust sales across various markets.
Aug. 9, 2018, 11:22 a.m.
Publisher: moneycontrol.com

-->